The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia. The main questions it aims to answer are: * Does video game-facilitated group activity enhance the quality of life as measured by a standardized scale (WHOQOL) in patients with schizophrenia hospitalized in a psychiatric hospital? * Can video game-facilitated group activity promote social function as measured by a specific scale (PSP) in patients with schizophrenia hospitalized in a psychiatric hospital? Researchers will compare video game-facilitated group activity to regular occupational therapy to see if the intervention is beneficial to patients with chronic schizophrenia. Participants will: * Attend to video game-facilitated group activity or regular occupational therapy three times a week for 12 weeks. * Receive assessments upon and after the 12-week intervention, and another 12 weeks after the intervention ends.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
64
The intervention is a 12-week group activity program for each participant in the intervention group, and the program consists of three 50-minute video game facilitated group activity sessions per week. Participants in the intervention group will engage in those group activity session which will be mediated by the game of Super Mario Party on Nintendo Switch.
Tsao-Tun Psychiatric Center, Ministry of Health and Welfare
Nantou City, Taiwan, Taiwan
The changes of quality of life
The changes of quality of life will be assessed by the World Health Organization Quality of Life-BREF (WHOQOL-BREF).
Time frame: The outcome will be assessed at baseline, week 12, and week 24.
The changes of social function.
The changes of social function will be evaluated by the Personal and Social Performance Scale (PSP).
Time frame: The outcome will be assessed at baseline, week 12, and week 24
The changes of cerebral blood flow.
The changes in cerebral blood be measured by Near-Infrared Spectroscopy (NIRS).
Time frame: The outcome will be assessed at baseline and week 12.
The change of cognitive function.
The Montreal Cognitive Assessment (MoCA) will be used to evaluate changes in cognitive function.
Time frame: The outcome will be assessed at baseline and week 12.
The change of psychiatric symptoms.
The Brief Psychiatric Rating Scale (BPRS) will be used to assess changes in positive and negative psychiatric symptoms.
Time frame: The outcome will be assessed at baseline and week 12.
The change of physical fitness
Physical fitness assessments will be conducted to measure changes in participants' physical fitness levels, including cardiopulmonary endurance, the strength and flexibility of upper and lower limbs, as well as dynamic and static balance. * The cardiopulmonary endurance would be measured by 6-minute walk test and march-in-place test. * The upper limbs strength will be measured by arm curl test and hand grip strength test. * The lower limbs strength will be measured by 30-second chair stand test. * The upper limbs flexibility will be measured by back scratch test. * The lower limbs flexibility will be measured by chair sit-and-reach test. * The dynamic balance test will be measured by chair stand and obstacle walk test. * The static balance test will be measured by one-leg stand test with eyes open.
Time frame: The outcome will be assessed at baseline and week 12.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.